Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 11.08 CHF -1.07%
Market Cap: 457.2m CHF
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+38%
Revenue
Forecast
+1%
Operating Income
Forecast
+25%
Net Income
Forecast
N/A

Wall Street
Price Targets

MEDX Price Targets Summary
Medmix Ltd

Wall Street analysts forecast MEDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDX is 22.95 CHF with a low forecast of 20.2 CHF and a high forecast of 26.25 CHF.

MEDX Lowest Forecast
Wall Street Target
20.2 CHF
82% Upside
MEDX Average Forecast
Wall Street Target
22.95 CHF
107% Upside
MEDX Highest Forecast
Wall Street Target
26.25 CHF
137% Upside
Lowest
Price Target
20.2 CHF
82% Upside
Average
Price Target
22.95 CHF
107% Upside
Highest
Price Target
26.25 CHF
137% Upside
Medmix Ltd Competitors:
Price Targets
ISRG
Intuitive Surgical Inc
27% Upside
MOVE
Medacta Group SA
15% Upside
COH
Cochlear Ltd
12% Upside
S
688212
Shanghai Aohua Photoelectricity Endoscope Co Ltd
44% Upside
ISRG
Intuitive Surgical Inc
27% Upside
MOVE
Medacta Group SA
15% Upside
COH
Cochlear Ltd
12% Upside
S
688212
Shanghai Aohua Photoelectricity Endoscope Co Ltd
44% Upside
IRMD
IRadimed Corp
36% Upside
1789
AK Medical Holdings Ltd
5% Upside
LMAT
LeMaitre Vascular Inc
28% Upside

Revenue
Forecast

Revenue Estimate
Medmix Ltd

For the last 5 years the compound annual growth rate for Medmix Ltd's revenue is 3%. The projected CAGR for the next 3 years is 4%.

3%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medmix Ltd

For the last 5 years the compound annual growth rate for Medmix Ltd's operating income is -19%. The projected CAGR for the next 3 years is 20%.

-19%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medmix Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
What are analyst estimates?

See Also

Summary
MEDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDX stock valuation using valuation multiples.
Wall Street Estimates
MEDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEDX's stock price target?
Price Target
22.95 CHF

According to Wall Street analysts, the average 1-year price target for MEDX is 22.95 CHF with a low forecast of 20.2 CHF and a high forecast of 26.25 CHF.

What is Medmix Ltd's Revenue forecast?
Projected CAGR
4%

For the last 5 years the compound annual growth rate for Medmix Ltd's revenue is 3%. The projected CAGR for the next 3 years is 4%.

What is Medmix Ltd's Operating Income forecast?
Projected CAGR
20%

For the last 5 years the compound annual growth rate for Medmix Ltd's operating income is -19%. The projected CAGR for the next 3 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.